Urofill vs. PMMA for Penile Girth Enhancement: What Patients Should Know

Dr. Luis Casavantes | Dr. Palmira Morales
Avanti Derma, Tijuana, Mexico

Patients researching nonsurgical girth enhancement in the United States often come across the term "Urofill." It is worth understanding what it is, what it is not, and how it compares to the permanent options a patient may also be considering.

What Urofill Is

Urofill is a proprietary technique that uses hyaluronic acid (HA) fillers for penile girth enhancement. Different clinics may use different specific HA products; the common denominator is that the material is HA-based, cross-linked to varying degrees, and reversible with hyaluronidase.

Urofill is not a distinct material class. It is a marketed treatment protocol using HA — one of the three main filler classes discussed in the girth enhancement literature (see our full comparison of HA, PMMA and Ellansé).

The Mechanistic Difference from PMMA

HA-based enhancement (including Urofill) adds volume by attracting water into the injected tissue. The material integrates temporarily and is metabolized over 9–14 months in the penile shaft. It is reversible at any point via hyaluronidase.

PMMA-based enhancement uses non-degradable microspheres that provide a permanent scaffold. The result is designed to last for the patient's lifetime. It is not reversible.

Neither approach is inherently superior. They are different tools for different clinical situations and different patient priorities. Some clinics attempt to combine both in the same session — an approach whose clinical rationale is not as sound as it is marketed to be.

When HA (Urofill) Makes Clinical Sense

• A patient who has never had a filler in this anatomy and wants to experience the result before committing.

• A patient whose risk tolerance for permanence is low.

• A patient who anticipates changing preferences over time.

• A patient in a jurisdiction where PMMA is not readily available and who is not willing to travel.

When PMMA Makes Clinical Sense

• A patient who has already had HA and knows the outcome they want to preserve.

• A patient whose priority is a stable, durable result without repeat procedures every 12–18 months.

• A patient who has been thoroughly screened for both anatomical and psychological readiness.

• A patient who has selected a provider with documented long-term experience in this specific procedure.

Cost Over Time

A single Urofill session costs less than a comparable PMMA session, but Urofill requires re-treatment. The cumulative cost of maintaining HA volume over 10 years often meets or exceeds the one-time cost of a PMMA result. This is not a reason to choose PMMA — it is a reason to be clear-eyed about the full economic picture when comparing options.

Safety Profiles

Both HA and PMMA have well-documented safety profiles when performed by experienced providers on well-selected patients. Complications in either class cluster around the same preventable factors — poor patient selection, inappropriate technique, and volume delivered too aggressively.

The safety difference is not about the material. It is about reversibility. If something goes wrong with an HA result, it can be dissolved. If something goes wrong with a PMMA result, the correction pathway is more complex. This is why PMMA demands a higher standard of provider experience and patient selection, not because it is unsafe.

Clinical Takeaways

• Urofill is HA-based, temporary, and reversible. PMMA is permanent and non-reversible.

• The choice between them is a clinical decision downstream of anatomy, goals, and risk tolerance.

• A consultation that presents only one of these options without explaining the other is incomplete.

• Cost per session and cost over ten years are different numbers. Both are worth calculating.

• Safety is a function of provider experience and patient selection more than of material.

Bibliography

1. Casavantes, L., Lemperle, G., Morales, P. "Penile Girth Enhancement with PMMA-Based Soft Tissue Fillers." J Sex Med 13, no. 9 (2016): 1414–1422.

2. Manfredi, C., Romero Otero, J., Djinovic, R. "Penile Enhancement: A Comprehensive and Current Perspective." Current Urology (2024). PMC12076428.

3. Pang, K.H., et al. "Complications and Outcomes Following Injection of Foreign Material into the Male External Genitalia." Int J Impot Res (2023).